E
Ekso Bionics Holdings, Inc.
EKSO
$0.4046
$0.02476.50%
E
Sell
2/7/2025Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 2/7/2025 due to a decline in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 2/7/2025 due to a decline in the volatility index.
D
Sell
1/23/2025Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 1/23/2025 due to an increase in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 1/23/2025 due to an increase in the volatility index and total return index.
E
Sell
1/6/2025Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 1/6/2025 due to a noticeable decline in the total return index, growth index and volatility index. Total revenue declined 16.59% from $4.95M to $4.13M, and EBIT declined 13.02% from -$2.34M to -$2.64M.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 1/6/2025 due to a noticeable decline in the total return index, growth index and volatility index. Total revenue declined 16.59% from $4.95M to $4.13M, and EBIT declined 13.02% from -$2.34M to -$2.64M.
D
Sell
10/11/2024Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 10/11/2024 due to an increase in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 10/11/2024 due to an increase in the volatility index and total return index.
E
Sell
9/25/2024Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 9/25/2024 due to a decline in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 9/25/2024 due to a decline in the volatility index.
D
Sell
9/5/2024Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 9/5/2024 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 9/5/2024 due to an increase in the volatility index.
E
Sell
8/20/2024Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 8/20/2024 due to a decline in the total return index, volatility index and growth index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 8/20/2024 due to a decline in the total return index, volatility index and growth index.
D
Sell
6/3/2024Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 6/3/2024 due to an increase in the valuation index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 6/3/2024 due to an increase in the valuation index.
E
Sell
5/17/2024Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 5/17/2024 due to a decline in the total return index and volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 5/17/2024 due to a decline in the total return index and volatility index.
D
Sell
1/4/2024Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 1/4/2024 due to a noticeable increase in the total return index and volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 1/4/2024 due to a noticeable increase in the total return index and volatility index.
E
Sell
12/15/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 12/15/2023 due to a decline in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 12/15/2023 due to a decline in the volatility index.
D
Sell
11/27/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 11/27/2023 due to an increase in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 11/27/2023 due to an increase in the volatility index and total return index.
E
Sell
11/9/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 11/9/2023 due to a decline in the growth index, volatility index and solvency index. Debt to equity increased from 0.37 to 0.44, operating cash flow declined 15.5% from -$2.9M to -$3.35M, and total revenue declined 2.04% from $4.7M to $4.61M.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 11/9/2023 due to a decline in the growth index, volatility index and solvency index. Debt to equity increased from 0.37 to 0.44, operating cash flow declined 15.5% from -$2.9M to -$3.35M, and total revenue declined 2.04% from $4.7M to $4.61M.
D
Sell
10/30/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 10/30/2023 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 10/30/2023 due to an increase in the volatility index.
E
Sell
10/11/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 10/11/2023 due to a decline in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 10/11/2023 due to a decline in the volatility index and total return index.
D
Sell
9/25/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 9/25/2023 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 9/25/2023 due to an increase in the volatility index.
E
Sell
9/6/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 9/6/2023 due to a decline in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 9/6/2023 due to a decline in the volatility index and total return index.
D
Sell
8/18/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 8/18/2023 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 8/18/2023 due to an increase in the volatility index.
E
Sell
8/1/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 8/1/2023 due to a decline in the volatility index, solvency index and total return index. Debt to equity increased from 0.31 to 0.37, and the quick ratio declined from 2.21 to 1.81.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 8/1/2023 due to a decline in the volatility index, solvency index and total return index. Debt to equity increased from 0.31 to 0.37, and the quick ratio declined from 2.21 to 1.81.
D
Sell
7/21/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 7/21/2023 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 7/21/2023 due to an increase in the volatility index.
E
Sell
7/3/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 7/3/2023 due to a decline in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 7/3/2023 due to a decline in the volatility index and total return index.
D
Sell
6/14/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 6/14/2023 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 6/14/2023 due to an increase in the volatility index.
E
Sell
5/26/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 5/26/2023 due to a decline in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 5/26/2023 due to a decline in the volatility index and total return index.
D
Sell
5/9/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 5/9/2023 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 5/9/2023 due to an increase in the volatility index.
E
Sell
4/21/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 4/21/2023 due to a decline in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 4/21/2023 due to a decline in the volatility index.
D
Sell
4/3/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 4/3/2023 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.3293 to -$0.2415, and total revenue increased 6.67% from $3.33M to $3.55M.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 4/3/2023 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.3293 to -$0.2415, and total revenue increased 6.67% from $3.33M to $3.55M.
E
Sell
3/15/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 3/15/2023 due to a decline in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 3/15/2023 due to a decline in the volatility index.
D
Sell
3/14/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 03/14/2023.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 03/14/2023.
D
Sell
2/10/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 2/10/2023 due to an increase in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 2/10/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 02/08/2023.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 02/08/2023.
D
Sell
1/25/2023Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 1/25/2023 due to a decline in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 1/25/2023 due to a decline in the volatility index.
D
Sell
1/4/2023Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 1/4/2023 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 1/4/2023 due to an increase in the volatility index.
D
Sell
12/16/2022Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 12/16/2022 due to a decline in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 12/16/2022 due to a decline in the volatility index and total return index.
D
Sell
11/28/2022Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 11/28/2022 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 11/28/2022 due to an increase in the volatility index.
D
Sell
11/10/2022Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 11/10/2022 due to a decline in the growth index, volatility index and solvency index. The quick ratio declined from 7.32 to 4.15, earnings per share declined from -$0.2311 to -$0.3293, and debt to equity increased from 0.06 to 0.08.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 11/10/2022 due to a decline in the growth index, volatility index and solvency index. The quick ratio declined from 7.32 to 4.15, earnings per share declined from -$0.2311 to -$0.3293, and debt to equity increased from 0.06 to 0.08.
D
Sell
8/1/2022Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 8/1/2022 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.363 to -$0.2311, total revenue increased 34.98% from $2.57M to $3.47M, and EBIT increased 23.79% from -$4.24M to -$3.23M.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 8/1/2022 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.363 to -$0.2311, total revenue increased 34.98% from $2.57M to $3.47M, and EBIT increased 23.79% from -$4.24M to -$3.23M.
D
Sell
7/13/2022Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 7/13/2022 due to a decline in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 7/13/2022 due to a decline in the volatility index and total return index.
D
Sell
6/27/2022Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 6/27/2022 due to an increase in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 6/27/2022 due to an increase in the volatility index and total return index.
D
Sell
5/31/2022Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 5/31/2022 due to an increase in the valuation index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 5/31/2022 due to an increase in the valuation index.
E
Sell
5/13/2022Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/5/2022Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 05/05/2022.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 05/05/2022.
E
Sell
5/1/2022Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D on 5/1/2022 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.2563 to -$0.363, total revenue declined 37.02% from $4.08M to $2.57M, and operating cash flow declined 36.78% from -$3.08M to -$4.21M.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D on 5/1/2022 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.2563 to -$0.363, total revenue declined 37.02% from $4.08M to $2.57M, and operating cash flow declined 36.78% from -$3.08M to -$4.21M.
D
Sell
4/21/2022Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D on 4/20/2022 due to a decline in the growth index, volatility index and solvency index. EBIT declined 63.21% from -$2.79M to -$4.55M, earnings per share declined from -$0.1665 to -$0.2563, and the quick ratio declined from 9.96 to 6.57.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D on 4/20/2022 due to a decline in the growth index, volatility index and solvency index. EBIT declined 63.21% from -$2.79M to -$4.55M, earnings per share declined from -$0.1665 to -$0.2563, and the quick ratio declined from 9.96 to 6.57.
D
Sell
11/10/2021Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 11/10/2021.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 11/10/2021.
D
Sell
11/8/2021Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index. Operating cash flow declined 80.3% from -$2M to -$3.61M, and EBIT declined 6.66% from -$3.14M to -$3.35M.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index. Operating cash flow declined 80.3% from -$2M to -$3.61M, and EBIT declined 6.66% from -$3.14M to -$3.35M.
D
Sell
5/1/2020Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 5/1/2020 due to an increase in the solvency index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 5/1/2020 due to an increase in the solvency index.
D
Sell
4/8/2020Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 4/8/2020 due to a noticeable increase in the valuation index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 4/8/2020 due to a noticeable increase in the valuation index.
E
Sell
3/24/2020Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 3/24/2020 due to a decline in the growth index, valuation index and total return index. Earnings per share declined from $0.0027 to -$0.0402.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 3/24/2020 due to a decline in the growth index, valuation index and total return index. Earnings per share declined from $0.0027 to -$0.0402.
D
Sell
11/5/2019Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 11/5/2019 due to a noticeable increase in the growth index, solvency index and valuation index. Earnings per share increased from -$0.0434 to $0.0027, debt to equity declined from 0.8 to 0.58, and EBIT increased 25.26% from -$5.1M to -$3.81M.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 11/5/2019 due to a noticeable increase in the growth index, solvency index and valuation index. Earnings per share increased from -$0.0434 to $0.0027, debt to equity declined from 0.8 to 0.58, and EBIT increased 25.26% from -$5.1M to -$3.81M.
E
Sell
5/7/2019Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 5/7/2019 due to a decline in the growth index and efficiency index. Net income declined 58.54% from -$4.13M to -$6.55M, earnings per share declined from -$0.0659 to -$0.1007, and operating cash flow declined 0.45% from -$5.15M to -$5.18M.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 5/7/2019 due to a decline in the growth index and efficiency index. Net income declined 58.54% from -$4.13M to -$6.55M, earnings per share declined from -$0.0659 to -$0.1007, and operating cash flow declined 0.45% from -$5.15M to -$5.18M.
D
Sell
3/4/2019Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 3/4/2019 due to a decline in the solvency index and valuation index. Debt to equity increased from 1 to 1.83, and the quick ratio declined from 1.57 to 1.12.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 3/4/2019 due to a decline in the solvency index and valuation index. Debt to equity increased from 1 to 1.83, and the quick ratio declined from 1.57 to 1.12.
D
Sell
8/9/2018Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 8/9/2018 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 17.83% from $2.52M to $2.97M, operating cash flow increased 10.17% from -$6.75M to -$6.06M, and EBIT increased 5.9% from -$7.63M to -$7.18M.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 8/9/2018 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 17.83% from $2.52M to $2.97M, operating cash flow increased 10.17% from -$6.75M to -$6.06M, and EBIT increased 5.9% from -$7.63M to -$7.18M.
E
Sell
5/8/2018Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 5/8/2018 due to a decline in the total return index, valuation index and solvency index. Debt to equity increased from 0.33 to 0.45, and the quick ratio declined from 3.34 to 2.41.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 5/8/2018 due to a decline in the total return index, valuation index and solvency index. Debt to equity increased from 0.33 to 0.45, and the quick ratio declined from 3.34 to 2.41.
D
Sell
3/14/2018Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 3/14/2018 due to a decline in the efficiency index, growth index and valuation index. Net income declined 41.72% from -$6.34M to -$8.98M, total capital declined 22.7% from $36.69M to $28.36M, and EBIT declined 14.28% from -$7.08M to -$8.09M.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 3/14/2018 due to a decline in the efficiency index, growth index and valuation index. Net income declined 41.72% from -$6.34M to -$8.98M, total capital declined 22.7% from $36.69M to $28.36M, and EBIT declined 14.28% from -$7.08M to -$8.09M.
D
Sell
11/9/2017Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 11/9/2017 due to a noticeable increase in the solvency index, efficiency index and valuation index. Total capital increased 324.83% from $8.61M to $36.59M, the quick ratio increased from 1.94 to 5.4, and debt to equity declined from 4.25 to 0.23.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from E+ on 11/9/2017 due to a noticeable increase in the solvency index, efficiency index and valuation index. Total capital increased 324.83% from $8.61M to $36.59M, the quick ratio increased from 1.94 to 5.4, and debt to equity declined from 4.25 to 0.23.
E
Sell
8/8/2017Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 8/8/2017 due to a noticeable decline in the efficiency index, valuation index and solvency index. Debt to equity increased from -4.97 to 4.22.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 8/8/2017 due to a noticeable decline in the efficiency index, valuation index and solvency index. Debt to equity increased from -4.97 to 4.22.
D
Sell
5/18/2017Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 5/18/2017 due to an increase in the efficiency index and valuation index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 5/18/2017 due to an increase in the efficiency index and valuation index.
E
Sell
3/21/2017Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 3/21/2017 due to a decline in the efficiency index, total return index and volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to E+ from D- on 3/21/2017 due to a decline in the efficiency index, total return index and volatility index.
D
Sell
8/9/2016Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 8/9/2016 due to a decline in the growth index, solvency index and valuation index. Debt to equity increased from 0.01 to 0.05, total revenue declined 81.71% from $8.49M to $1.55M, and the quick ratio declined from 1.87 to 1.08.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 8/9/2016 due to a decline in the growth index, solvency index and valuation index. Debt to equity increased from 0.01 to 0.05, total revenue declined 81.71% from $8.49M to $1.55M, and the quick ratio declined from 1.87 to 1.08.
D
Sell
5/11/2016Upgraded
Ekso Bionics Holdings, Inc. (EKSOD) was upgraded to D from D- on 5/11/2016 due to an increase in the growth index and total return index. Total revenue increased 336.75% from $1.94M to $8.49M, earnings per share increased from -$0.779 to -$0.4403, and EBIT increased 0.15% from -$6.65M to -$6.64M.
Ekso Bionics Holdings, Inc. (EKSOD) was upgraded to D from D- on 5/11/2016 due to an increase in the growth index and total return index. Total revenue increased 336.75% from $1.94M to $8.49M, earnings per share increased from -$0.779 to -$0.4403, and EBIT increased 0.15% from -$6.65M to -$6.64M.
D
Sell
3/15/2016Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 3/15/2016 due to a large decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.0507 to -$0.1096, total revenue declined 33.34% from $2.92M to $1.94M, and EBIT declined 28.39% from -$5.18M to -$6.65M.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 3/15/2016 due to a large decline in the volatility index, total return index and growth index. Earnings per share declined from -$0.0507 to -$0.1096, total revenue declined 33.34% from $2.92M to $1.94M, and EBIT declined 28.39% from -$5.18M to -$6.65M.
D
Sell
1/12/2016Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D from D+ on 1/12/2016 due to a decline in the total return index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D from D+ on 1/12/2016 due to a decline in the total return index.
D
Sell
12/28/2015Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D+ from D on 12/28/2015 due to an increase in the total return index and valuation index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D+ from D on 12/28/2015 due to an increase in the total return index and valuation index.
D
Sell
11/30/2015Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D from D+ on 11/30/2015 due to a decline in the total return index and valuation index.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D from D+ on 11/30/2015 due to a decline in the total return index and valuation index.
D
Sell
11/13/2015Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D+ from D on 11/13/2015 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 37.89% from $2.11M to $2.92M.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D+ from D on 11/13/2015 due to a noticeable increase in the growth index, total return index and volatility index. Total revenue increased 37.89% from $2.11M to $2.92M.
D
Sell
8/14/2015Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D from D+ on 8/14/2015 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 3.37 to 2.23, and total capital declined 26.94% from $19.2M to $14.03M.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D from D+ on 8/14/2015 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 3.37 to 2.23, and total capital declined 26.94% from $19.2M to $14.03M.
D
Sell
8/3/2015Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D+ from D on 8/3/2015 due to a significant increase in the efficiency index and growth index. Operating cash flow increased 41.16% from -$2.71M to -$3.83M, and total revenue increased 14.11% from $1.48M to $1.69M.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D+ from D on 8/3/2015 due to a significant increase in the efficiency index and growth index. Operating cash flow increased 41.16% from -$2.71M to -$3.83M, and total revenue increased 14.11% from $1.48M to $1.69M.
D
Sell
5/14/2015Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 5/14/2015 due to a large increase in the volatility index and total return index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 5/14/2015 due to a large increase in the volatility index and total return index.
D
Sell
3/20/2015Downgrade
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 3/20/2015 due to a significant decline in the efficiency index, valuation index and growth index. Total capital declined 495.63% from -$5.79M to $22.92M, net income declined 267.62% from $12.02M to -$20.16M, and operating cash flow declined 24.38% from -$3.59M to -$2.71M.
Ekso Bionics Holdings, Inc. (EKSO) was downgraded to D- from D on 3/20/2015 due to a significant decline in the efficiency index, valuation index and growth index. Total capital declined 495.63% from -$5.79M to $22.92M, net income declined 267.62% from $12.02M to -$20.16M, and operating cash flow declined 24.38% from -$3.59M to -$2.71M.
D
Sell
2/2/2015Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 2/2/2015 due to an increase in the solvency index and volatility index.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D from D- on 2/2/2015 due to an increase in the solvency index and volatility index.
D
Sell
10/1/2014Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 10/1/2014 due to an increase in the solvency index, growth index and valuation index. Total revenue increased 12.75% from $1.06M to $1.2M, and EBIT increased 10.77% from -$3.89M to -$4.31M.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to D- from E+ on 10/1/2014 due to an increase in the solvency index, growth index and valuation index. Total revenue increased 12.75% from $1.06M to $1.2M, and EBIT increased 10.77% from -$3.89M to -$4.31M.
E
Sell
7/1/2014Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to E+ from E on 07/01/2014.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to E+ from E on 07/01/2014.
E
Sell
5/21/2014Upgraded
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to E from on 5/21/2014 due to a significant increase in the efficiency index, solvency index and total return index. Total capital increased 4,924% from -$1.48M to -$74.39M, net income increased 2,823.64% from -$2.8M to -$81.77M, and the quick ratio increased from 0.11 to 2.91.
Ekso Bionics Holdings, Inc. (EKSO) was upgraded to E from on 5/21/2014 due to a significant increase in the efficiency index, solvency index and total return index. Total capital increased 4,924% from -$1.48M to -$74.39M, net income increased 2,823.64% from -$2.8M to -$81.77M, and the quick ratio increased from 0.11 to 2.91.
NASDAQ
03/12/2025 4:00PM Eastern
Quotes delayed
